Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.53 - $2.0 $5,090 - $19,208
9,604 New
9,604 $19,000
Q4 2022

Feb 09, 2023

BUY
$0.58 - $1.2 $4,699 - $9,722
8,102 New
8,102 $5,000
Q4 2021

Feb 11, 2022

SELL
$4.09 - $7.16 $15,177 - $26,570
-3,711 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$5.8 - $8.02 $19,720 - $27,268
-3,400 Reduced 47.81%
3,711 $22,000
Q2 2021

Aug 10, 2021

SELL
$6.87 - $9.16 $14,523 - $19,364
-2,114 Reduced 22.92%
7,111 $59,000
Q1 2021

May 12, 2021

BUY
$7.67 - $13.77 $70,755 - $127,028
9,225 New
9,225 $79,000
Q1 2020

May 13, 2020

SELL
$5.79 - $11.83 $4,232 - $8,647
-731 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$3.9 - $6.16 $9,629 - $15,209
-2,469 Reduced 77.16%
731 $4,000
Q3 2019

Nov 12, 2019

SELL
$3.01 - $4.49 $32,860 - $49,017
-10,917 Reduced 77.33%
3,200 $14,000
Q2 2019

Aug 09, 2019

SELL
$2.8 - $4.14 $9,315 - $13,773
-3,327 Reduced 19.07%
14,117 $54,000
Q1 2019

May 13, 2019

BUY
$2.35 - $4.19 $25,549 - $45,553
10,872 Added 165.43%
17,444 $72,000
Q4 2018

Feb 06, 2019

SELL
$2.17 - $3.8 $8,200 - $14,360
-3,779 Reduced 36.51%
6,572 $14,000
Q3 2018

Nov 08, 2018

BUY
$3.0 - $4.05 $31,053 - $41,921
10,351 New
10,351 $40,000
Q2 2018

Aug 14, 2018

SELL
$3.15 - $4.7 $60,656 - $90,503
-19,256 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$2.5 - $4.45 $48,140 - $85,689
19,256 New
19,256 $86,000
Q3 2017

Nov 15, 2017

SELL
$2.75 - $3.95 $3,113 - $4,471
-1,132 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,132
1,132 $4,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.